How is the rise of GLP-1 weight loss drugs affecting market action? Jim Cramer explains

CNBC's Jim Cramer on Wednesday said many on Wall Street are already anticipating the effects of GLP-1 weight loss drugs.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.